Maximize your chances for success against difficult protein targets.
Vaccinex leverages its ActivMab® Technology to provide a source of native antigen embedded in a viral lipid membrane for antibody discovery.
Vaccinex offers two antigenically distinct poxviruses to maximize specificity for the target antigen. Both the mammalian and the avian poxviruses are compatible with in vivo and in vitro antibody discovery methods.
Our Biosafety Level 1 antigen virions efficiently incorporate multi-pass proteins into their outer membrane and are released into the culture medium.
Contact us for a quote or to learn more about ActivMab® Discovery Services
Learn more by viewing our On-demand Webinar: Antibody Discovery for Challenging Targets Powered by ActivMab® Technology